Vir Biotechnology, Inc. (VIR) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 2.00B USD. 52-week range 4.82 to 11.96 USD. Data as of 2026-10-09.
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal ...